Skip to main content
Advertising

Originally published December 6, 2013 at 6:37 AM | Page modified December 6, 2013 at 10:34 AM

  • Share:
           
  • Comments (0)
  • Print

23andMe to halt health-related genetic reports

Genetic testing company 23andMe Inc. will comply with a Food and Drug Administration directive to stop providing access to health-related reports from its tests during a regulatory review.


Most Popular Comments
Hide / Show comments
No comments have been posted to this article.
Start the conversation >

advertising

MOUNTAIN VIEW, Calif. —

Genetic testing company 23andMe Inc. will comply with a Food and Drug Administration directive to stop providing access to health-related reports from its tests during a regulatory review.

The Mountain View, Calif., company said late Thursday that it will continue to provide ancestry-related information to customers and raw genetic data without interpretation. Those customers could receive additional, health-related information in the future, depending on whether the FDA grants marketing authorization.

Customers who bought kits since the FDA order came out late last month also will be eligible for refunds.

FDA representatives did not immediately return a phone call from The Associated Press seeking comment on the company's announcement.

23andMe's saliva-based test kit, launched more than 5 years ago, claims to tell customers if they are at risk for more than 250 diseases and health conditions. The company sells its tests online. Customers receive a small tube in the mail, which they return to the company with a saliva sample for DNA analysis.

The FDA says only medical tests that have been cleared by the government are permitted to make such claims.

Last month, the agency had ordered 23andMe to stop marketing its test, warning that erroneous results could cause customers to seek unnecessary or ineffective medical care. The FDA warning letter stated that even after numerous meetings and email exchanges with the company, the agency still had no assurance that the firm has analytically or clinically validated its technology.

23andMe was co-founded by Anne Wojcicki, who recently separated from her husband, Google co-founder Sergey Brin. Both Google and Brin have invested millions in the privately held company over the years.



News where, when and how you want it

Email Icon

Get ready for 2015

Get ready for 2015

The Seattle Times 12-month wall calendar features hand-picked photos of life in the Pacific Northwest. Order while supplies last!

Advertising

Advertising


Advertising
The Seattle Times

The door is closed, but it's not locked.

Take a minute to subscribe and continue to enjoy The Seattle Times for as little as 99 cents a week.

Subscription options ►

Already a subscriber?

We've got good news for you. Unlimited seattletimes.com content access is included with most subscriptions.

Subscriber login ►